4.8 Article

TNF signaling drives myeloid-derived suppressor cell accumulation

Journal

JOURNAL OF CLINICAL INVESTIGATION
Volume 122, Issue 11, Pages 4094-4104

Publisher

AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI64115

Keywords

-

Funding

  1. Ministry of Science and Technology of China [2012CB917103, 2012CB934003]
  2. National Natural Science Foundation of China [81030049, 31071261, 81001328]
  3. Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan

Ask authors/readers for more resources

TNF, an inflammatory cytokine that is enriched in the tumor microenvironment, promotes tumor growth and subverts innate immune responses to cancer cells. We previously reported that tumors implanted in TNF receptor-deficient (Tnfr(-/-)) mice are spontaneously rejected; however, the molecular mechanisms underlying this rejection are unclear. Here we report that TNF signaling drives the peripheral accumulation of myeloid-derived suppressor cells (MDSCs). MDSCs expand extensively during inflammation and tumor progression in mice and humans and can enhance tumor growth by repressing T cell-mediated antitumor responses. Peripheral accumulation of MDSCs was drastically impaired in Tnfr(-/-) mice. Signaling of TNFR-2, but not TNFR-1, promoted MDSC survival through upregulation of cellular FLICE-inhibitory protein (c-FLIP) and inhibition of caspase-8 activity. Loss of TNFRs impaired the induction of MDSCs from bone marrow cells, but this could be reversed by treatment with caspase inhibitors. These results demonstrate that TNFR-2 signaling promotes MDSC survival and accumulation and helps tumor cells evade the immune system.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available